-
US stock market closes: two generations of leading companies run counter to each other. Novo Nordisk sets new highs and Pfizer slashes performance expectations
JPMorgan Chase CEO Jamie Damon warned at Friday's earnings meeting that this could be the most dangerous moment in the world in decades. The new round of Palestinian-Israeli conflict, combined with t ... -
Pfizer lowered its annual revenue guidance again: COVID-19's products were not as expected or a major layoff was planned
Affected by the lower than expected sales of star COVID-19 products, Pfizer, the "Cosmic Pharmaceutical Factory", also has to live a tight life. On October 13th local time, Pfizer (PFE. US) once agai ... -
Pfizer Lowers Annual Revenue Expectations, Implying layoffs
[Pfizer cuts its annual revenue forecast, implying layoffs] According to a Reuters report on the 14th local time, the US biopharmaceutical company Pfizer cut its annual revenue forecast by about 13% ... -
Downgrading 2023 performance guidelines Pfizer Paxlovid cannot be sold anymore
On October 13th, Pfizer released a notice titled "Pfizer Revises US Government Paxlovid Supply Agreement and Updates 2023 Performance Guidelines", stating that due to the transition of Paxlovid (Nema ... -
Pfizer to close two production facilities in North Carolina
Pfizer will close two production facilities in North Carolina. Pfizer stated in an email statement that the company will close its Kit Creek and Durham clinical manufacturing facilities in North Caro ...- chensong665124
- 2023-10-28
- サポート
- に反対
- 返信
- コレクション
-
The sluggish sales of COVID-19 Pharmaceutical delayed the performance, and Pfizer plans to cut billions of dollars in expenditure, announcing global layoffs
The once popular Pfizer COVID-19 medicine has gone unnoticed. Recently, Pfizer announced that its oral drug Paxlovid, an anti COVID-19 drug, will be converted to self funded mode. Meanwhile, the pric ... -
Pfizer lost $2.382 billion in the third quarter, the first quarterly loss since 2019
On October 31st local time, American pharmaceutical company Pfizer announced its third quarter report, with revenue of $44.247 billion in the first three quarters, a year-on-year decrease of 42%; The ... -
Pfizer, an old friend of the Expo, strives to promote local innovation and global synchronization
We hope that China will join the global market from the beginning of research and development. By the end of 2022, we have achieved the goal of 80% of product research and development and launch in s ... -
Pfizer Nose Spray Migraine Medicine Makes Its First Show at the Expo, Expected to Landing in Boao, Hainan early next year
Ruimei Jipan orally disintegrating tablets have been launched in the pilot area of Boao Lecheng and the Greater Bay Area of Guangdong, Hong Kong, and Macao, and have now benefited hundreds of migrain ... -
Pfizer will lay off 500 employees in the UK to reduce costs
Pfizer will lay off 500 employees in the UK to reduce costs. Pfizer announced on November 14th that as part of its $3.5 billion cost reduction plan, the company will lay off 500 employees at its prod ... -
Pfizer and Astellar's prostate cancer treatment Xtandi has been approved by the US FDA
On November 16th, Pfizer and Astellar jointly announced that their prostate cancer drug XTANDI has been approved by the US Food and Drug Administration (FDA) for the treatment of non metastatic castr ... -
Pfizer China Dismiss Star Pneumonia Vaccine Product Team and Change to Shanghai Pharmaceutical Agency for Promotion and Sales
On November 24th, a netizen on social media platform Xiaohongshu reported that the Pfizer China 13 valent pneumococcal polysaccharide conjugate vaccine (PCV13 vaccine, product name: Pei'er 13, Preven ... -
Pfizer 13 valent pneumococcal polysaccharide conjugate vaccine, to be promoted by Shangyao distribution
Recently, a netizen said on the social platform that Pfizer's 13 price pneumococcal polysaccharide conjugate vaccine (trade name: Peier 13) team had all been laid off. After that, Science Park was re ... -
Behind the layoffs of Pfizer's vaccine team: The issuance of 13 batches of Star Vaccine Pei'er has plummeted sharply, and it has also been surrounded by domestic production
Recently, Pfizer's vaccine team in China reported layoffs. Its 13 valent pneumococcal polysaccharide conjugate vaccine (PCV13 vaccine, trade name: Pei'er 13, Prevenar 13), which is currently being so ... -
Pfizer China and Guangzhou Municipal Government Sign Strategic Cooperation
On November 29th, according to Pfizer's official WeChat account, Pfizer China signed a strategic cooperation memorandum with the Guangzhou Municipal Government on November 28th. According to the memo ... -
Pfizer was sued by the US Texas prosecutor for "improperly stating the effectiveness of COVID-19 vaccine"
[Accused by the US Texas prosecutor of "improperly stating the effectiveness of COVID-19 vaccine" Pfizer responded.] On November 30 local time, the US Texas Attorney General Paxton sued Pfizer, accus ... -
Pfizer China President: Breaking the "Information Island" of Digital Healthcare
Even in rural areas, you can also see expert accounts in Beijing, where you can prescribe online, buy medicine with just one click, and deliver it to your home in half an hour... Unconsciously, "digi ... -
Pfizer's failed development of oral weight loss drugs has no hope of turning around in the short term
The best performing companies in the healthcare sector this year have all benefited from the weight loss drug boom. Pfizer also hopes to make a comeback with an oral weight loss drug, but the latest ... -
Top 20 US Stock Deals: Pfizer Encounters Double Killing Lawsuit between Diet Drugs and COVID-19 Vaccine
[The top 20 US stock turnover: Pfizer suffered a double battle between weight-loss drugs and COVID-19 vaccine litigation] The 12th Pfizer Pharmaceutical closed down 5.12%, the largest one-day decline ... -
Taojin Oral GLP-1 Weight Loss Drug: Pfizer Bets on "Small Molecules" at Risk, "Oral Peptides" Opportunity Comes?
On December 9th, Science and Technology Innovation Board Daily reported (Reporter Xu Hong) that "the market value of overseas leading companies has skyrocketed" and "A-share related sectors have been ...